Cardiac resynchronization therapy (CRT) is widely used to improve cardiac pump function and prolong life in patients with heart failure, but 30–50% do not respond to treatment Appropriate selection of ...

Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony. We ...

A Baylor College of Medicine multi-institution, collaborative study to determine the effectiveness and safety of commonly used pacing treatments for cardiac resynchronization therapy in people with ...

BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and IsraelAddressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart FailureThis ...

We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death ...

Dr. Arthur Moss answers the question: 'Cardiac Resynchronization Device?' — -- Question: What is a cardiac resynchronization device, and is it the same as a pacemaker? Answer:Well, in a way it's ...

Methods We searched electronic databases and other sources for reports of randomized trials using a parallel or crossover design. We included studies involving patients with heart failure receiving ...

CRT is a surgical procedure in which doctors implant a pacemaker in both the right and left sides of the heart to help your heart’s chambers beat together. The goal is to improve heart pumping ...

CRT Innovation is the First to Offer Exclusive OptiVol® Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management “Atrial arrhythmias are the number one cause of ...

The Cardiac Resynchronization in Heart Failure (CARE-HF) [1] trial was an open-label, randomized, controlled study that evaluated the effects of cardiac resynchronization therapy (CRT) on morbidity ...

AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates MINNEAPOLIS - Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval ...